This is a global health crisis waiting to happen. Incentives need to be created for pharma to create many new broad spectrum antibiotics. Longer patents, financial or tax incentives, even subsidies, whatever it takes.
The solution is already rapidly inbound, few are talking about it for some reason though. Within three or so years, everyone will be talking about the obvious solution to it. You'll see dozens upon dozens of articles pop up in that time, talking about the same thing...
For less than $20,000 you can start experimenting with new attacks on infection and resistance, in your kitchen (so to speak; I'd suggest a real lab), using CRISPR. You can order the bacterial samples you need very inexpensively, and just begin working on it. Based on the current legal position of Broad and Berkeley, You can also do any work you want around Cas9 or Cpf1 in the US, without concerns for licensing/patents (until or less you plan to commercialize).
Only a few interesting things are out there about it now, that'll change very soon:
